Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants

Nav

General Info

Geography

United States of America (USA)

North Carolina

Time period covered

01/1997 - 12/2012

Data type

Scientific literature

Keywords

Drug resistance, MRSA infection, Mortality

Citation

Authors

Thaden JT, Ericson JE, Cross H, Bergin SP, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PB, Antibacterial Resistance Leadership Group

Journal

Pediatr Infect Dis J

Volume

Issue

Pages

1175-9

Publication year

2015

Suggested citation

Thaden JT, Ericson JE, Cross H, Bergin SP, Messina JA, Fowler VG Jr, Benjamin DK Jr, Clark RH, Hornik CP, Smith PB, Antibacterial Resistance Leadership Group. Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants. Pediatr Infect Dis J. 2015; 34(11): 1175-9.

DOI

10.1097/INF.0000000000000850

PMID

26222060

GHDx Entry last modified on: Jan 31, 2024

Header sites

Search form

Main menu

Survival Benefit of Empirical Therapy for Staphylococcus aureus Bloodstream Infections in Infants

Nav